Log in

NASDAQ:HQY - Healthequity Stock Price, Forecast & News

$67.04
-0.39 (-0.58 %)
(As of 12/10/2019 08:37 AM ET)
Today's Range
$66.72
Now: $67.04
$68.21
50-Day Range
$55.82
MA: $61.07
$67.43
52-Week Range
$50.29
Now: $67.04
$85.07
Volume1.08 million shs
Average Volume687,150 shs
Market Capitalization$4.75 billion
P/E Ratio70.57
Dividend YieldN/A
Beta1.47
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HQY
CUSIPN/A
Phone801-727-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$287.24 million
Cash Flow$1.24 per share
Book Value$7.65 per share

Profitability

Net Income$73.90 million

Miscellaneous

Employees1,141
Market Cap$4.75 billion
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.


Healthequity (NASDAQ:HQY) Frequently Asked Questions

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) issued its quarterly earnings results on Tuesday, December, 3rd. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.14 by $0.33. The firm had revenue of $157.12 million for the quarter, compared to analysts' expectations of $152.38 million. Healthequity had a net margin of 13.03% and a return on equity of 11.31%. The company's revenue for the quarter was up 122.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.25 EPS. View Healthequity's Earnings History.

When is Healthequity's next earnings date?

Healthequity is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Healthequity.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity updated its FY 2020 After-Hours earnings guidance on Tuesday, December, 3rd. The company provided EPS guidance of 1.46-1.52 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.28. The company issued revenue guidance of $520-526 million, compared to the consensus revenue estimate of $517.31 million.

What price target have analysts set for HQY?

12 equities research analysts have issued 1-year price targets for Healthequity's stock. Their forecasts range from $56.00 to $102.00. On average, they anticipate Healthequity's stock price to reach $79.08 in the next year. This suggests a possible upside of 18.0% from the stock's current price. View Analyst Price Targets for Healthequity.

What is the consensus analysts' recommendation for Healthequity?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 1 hold rating, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.

What are Wall Street analysts saying about Healthequity stock?

Here are some recent quotes from research analysts about Healthequity stock:
  • 1. According to Zacks Investment Research, "HealthEquity raised fiscal 2020 guidance. Currently, HealthEquity is the third-largest HSA custodian by market share. These apart, the company’s 401(K) solution, which lowers cost, risk and work of managing a retirement plan, bodes well. Strong growth in Service and Custodial revenue segments instills optimism in the stock. On the flip side, HealthEquity had to incur huge costs resulting from a patient data breach in recent times. It faces stiff competition in Medical Services market. HealthEquity is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service. Reflective of the trends exhibited by the company, the stock underperformed its industry in a year’s time." (11/5/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We are upgrading the shares of from Neutral. Our price target remains $82, or roughly 38% above current levels. HQY shares have struggled since the company reported F3Q19 results earlier this month. We believe fundamentals remain strong as HQY continues to benefit from continued adoption of health savings accounts (HSA). The company continues to grow above market rates. In the most recent quarter, HQY’s HSA members grew by 22%, which compares with Webster Bank, which reported account growth of just 12%. Earnings continue to benefit from a higher interest environment, even with a slight moderation in 10-year interest rates lately." (12/17/2018)

Has Healthequity been receiving favorable news coverage?

Press coverage about HQY stock has been trending somewhat positive recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Healthequity earned a media sentiment score of 1.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Healthequity.

Are investors shorting Healthequity?

Healthequity saw a decrease in short interest in the month of November. As of November 15th, there was short interest totalling 4,960,000 shares, a decrease of 8.3% from the October 31st total of 5,410,000 shares. Based on an average trading volume of 817,200 shares, the short-interest ratio is presently 6.1 days. Currently, 7.2% of the company's stock are sold short. View Healthequity's Current Options Chain.

Who are some of Healthequity's key competitors?

What other stocks do shareholders of Healthequity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Input Capital (INP), Circle Oil (COP), Paypal (PYPL), Shopify (SHOP), Alibaba Group (BABA), Netflix (NFLX), Twilio (TWLO), Square (SQ) and Okta (OKTA).

Who are Healthequity's key executives?

Healthequity's management team includes the folowing people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 51)
  • Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 54)

Who are Healthequity's major shareholders?

Healthequity's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (3.10%), Voya Investment Management LLC (0.99%), TimesSquare Capital Management LLC (0.90%), Granahan Investment Management Inc. MA (0.85%), Eagle Asset Management Inc. (0.78%) and Stephens Investment Management Group LLC (0.70%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

Which major investors are selling Healthequity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Man Group plc, Stifel Financial Corp, Barclays PLC, Convergence Investment Partners LLC, Tygh Capital Management Inc., Morse Asset Management Inc and Envestnet Asset Management Inc.. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Darcy G Mott, Delano Ladd and Frank Corvino. View Insider Buying and Selling for Healthequity.

Which major investors are buying Healthequity stock?

HQY stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, TimesSquare Capital Management LLC, Copper Rock Capital Partners LLC, Voya Investment Management LLC, Granahan Investment Management Inc. MA, Millennium Management LLC, Summit Creek Advisors LLC and CWM LLC. View Insider Buying and Selling for Healthequity.

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $67.04.

How big of a company is Healthequity?

Healthequity has a market capitalization of $4.75 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe.View Additional Information About Healthequity.

What is Healthequity's official website?

The official website for Healthequity is http://www.healthequity.com/.

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]


MarketBeat Community Rating for Healthequity (NASDAQ HQY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  403 (Vote Outperform)
Underperform Votes:  316 (Vote Underperform)
Total Votes:  719
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel